Wyniki wyszukiwania "" - Agency for Health Technology Assessment and Tariff System

W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies

X

Edward Flatau and his place in the history of neurology

08 May, 2024

Opinion of the Transparency Council – dexamethasone

23 May, 2023

Opinion of the Transparency Council – amendments to part B of the drug programme B.70

23 May, 2023

Opinion of the Transparency Council – health policy programme of the City of Białystok

23 May, 2023

Opinion of the Transparency Council – health policy programme of the City of Zduńska Wola

23 May, 2023

Position of the Transparency Council – Adtralza (tralokinumab)

23 May, 2023

Meeting of the Transparency Council 20/2023 on 22 May 2023 – Update

22 May, 2023

Communication on the meeting of the Tariff Council on 11 May 2023

18 May, 2023

Communication on the meeting of the Tariff Council on 20 April 2023

18 May, 2023

The Transparency Council meeting 20/2023 on 22 May 2023

16 May, 2023

Opinion of the Transparency Council – desmopressin

16 May, 2023

Opinion of the Transparency Council – fentanyl

16 May, 2023

Opinion of the Transparency Council – paclitaxel

16 May, 2023

Opinion of the Transparency Council – carboplatin

16 May, 2023

Position of the Transparency Council – Forxiga (dapagliflozin)

16 May, 2023

Position of the Transparency Council – Forxiga (dapagliflozin)

16 May, 2023

Opinion of the Transparency Council – e-stethoscopes

16 May, 2023

Opinion of the Transparency Council – health policy programme of the Municipality of Kamieniec Ząbkowicki

16 May, 2023

Opinion of the Transparency Council – health policy programme of the Municipality of Piaseczno

16 May, 2023

The Transparency Council meeting 19/2023 on 15 May 2023

11 May, 2023

Opinion of the Transparency Council – valsartan + hydrochlorothiazide

10 May, 2023

Opinion of the Transparency Council – telmisartan + indapamide

10 May, 2023

Opinion of the Transparency Council – telmisartan + hydrochlorothiazide

10 May, 2023

Opinion of the Transparency Council – lisinopril + amlodipine

10 May, 2023

Home page